Rickert D E, deBethizy J D, Glover M R, Kedderis G L
Biochem Pharmacol. 1985 Dec 1;34(23):4163-8. doi: 10.1016/0006-2952(85)90210-2.
Previous work has suggested that quantitative differences in the in vitro and in vivo metabolism of mononitrotoluene isomers are a result of differences in the hepatic conjugation and oxidation of the first metabolic intermediates, the mononitrobenzyl alcohols. We have determined the steady-state kinetic parameters, Vmax, Km and V/K, for the metabolism of the nitrobenzyl alcohols by rat hepatic alcohol dehydrogenase, glucuronyltransferase, and sulfotransferase. 3-Nitrobenzyl alcohol was the best substrate for cytosolic alcohol dehydrogenase (Vmax = 1.48 nmoles/min/mg protein, V/K = 3.15 X 10(-3) nmoles/min/mg protein/microM, Km = 503 microM). Vmax and Km values for 4-nitrobenzyl alcohol were similar, but V/K was about 60% of that for 3-nitrobenzyl alcohol. 2-Nitrobenzyl alcohol was not metabolized by the alcohol dehydrogenase preparation used here, but it was metabolized to 2-nitrobenzoic acid by a rat liver mitochondrial preparation. 2-Nitrobenzyl alcohol was the best substrate for microsomal glucuronyltransferase (Vmax = 3.59 nmoles/min/mg protein, V/K = 11.28 X 10(-3) nmoles/min/mg protein/microM, Km = 373 microM). The Vmax for 3-nitrobenzyl alcohol was similar, but the V/K was about half and the Km was about twice that for 2-nitrobenzyl alcohol. The Vmax for 4-nitrobenzyl alcohol was about 40% and the V/K was about half that for 2-nitrobenzyl alcohol. The best substrate for cytosolic sulfotransferase was 4-nitrobenzyl alcohol (Vmax = 1.69 nmoles/min/mg protein, V/K = 37.21 X 10(-3) nmoles/min/mg protein/microM, Km = 48 microM). The Vmax values for the other two benzyl alcohols were similar, but the V/K and Km values were about 11 and 400%, respectively, of those for 4-nitrobenzyl alcohol. These data are in qualitative agreement with results obtained when the nitrobenzyl alcohols were incubated with isolated hepatocytes, but they do not allow quantitative modeling of the data from hepatocytes.
先前的研究表明,一硝基甲苯异构体在体外和体内代谢的定量差异是由于肝脏对第一种代谢中间体一硝基苄醇的结合和氧化存在差异所致。我们已经测定了大鼠肝脏乙醇脱氢酶、葡糖醛酸基转移酶和磺基转移酶代谢硝基苄醇的稳态动力学参数Vmax、Km和V/K。3-硝基苄醇是胞质乙醇脱氢酶的最佳底物(Vmax = 1.48纳摩尔/分钟/毫克蛋白,V/K = 3.15×10⁻³纳摩尔/分钟/毫克蛋白/微摩尔,Km = 503微摩尔)。4-硝基苄醇的Vmax和Km值相似,但V/K约为3-硝基苄醇的60%。本文所用的乙醇脱氢酶制剂不能代谢2-硝基苄醇,但大鼠肝脏线粒体制剂可将其代谢为2-硝基苯甲酸。2-硝基苄醇是微粒体葡糖醛酸基转移酶的最佳底物(Vmax = 3.59纳摩尔/分钟/毫克蛋白,V/K = 11.28×10⁻³纳摩尔/分钟/毫克蛋白/微摩尔,Km = 373微摩尔)。3-硝基苄醇的Vmax相似,但V/K约为2-硝基苄醇的一半,Km约为2-硝基苄醇的两倍。4-硝基苄醇的Vmax约为2-硝基苄醇的40%,V/K约为2-硝基苄醇的一半。胞质磺基转移酶的最佳底物是4-硝基苄醇(Vmax = 1.69纳摩尔/分钟/毫克蛋白,V/K = 37.21×10⁻³纳摩尔/分钟/毫克蛋白/微摩尔,Km = 48微摩尔)。其他两种苄醇的Vmax值相似,但V/K和Km值分别约为4-硝基苄醇的11倍和400%。这些数据与硝基苄醇与分离的肝细胞一起孵育时获得的结果在定性上一致,但它们不允许对来自肝细胞的数据进行定量建模。